X0306 4 2021-01-19 false 0001531048 Inari Medical, Inc. NARI 0001806431 Hykes Andrew C/O INARI MEDICAL, INC. 9 PARKER, SUITE 100 IRVINE CA 92618 false true false false Chief Operating Officer Common Stock 2021-01-19 4 S false 300.00 94.2067 D 204641.00 D Common Stock 2021-01-19 4 S false 900.00 95.3778 D 203741.00 D Common Stock 2021-01-19 4 S false 600.00 96.6917 D 203141.00 D Common Stock 2021-01-19 4 S false 600.00 97.945 D 202541.00 D Common Stock 2021-01-19 4 S false 600.00 98.715 D 201941.00 D Common Stock 2021-01-19 4 S false 400.00 94.3225 D 201541.00 D Common Stock 2021-01-19 4 S false 800.00 95.2338 D 200741.00 D Common Stock 2021-01-19 4 S false 600.00 96.69 D 200141.00 D Common Stock 2021-01-19 4 S false 599.00 97.9689 D 199542.00 D Common Stock 2021-01-19 4 S false 601.00 98.7105 D 198941.00 D Common Stock 2021-01-19 4 S false 400.00 94.3225 D 198541.00 D Common Stock 2021-01-19 4 S false 700.00 95.2386 D 197841.00 D Common Stock 2021-01-19 4 S false 666.00 96.6381 D 197175.00 D Common Stock 2021-01-19 4 S false 923.00 98.1637 D 196252.00 D Common Stock 2021-01-19 4 S false 311.00 98.7459 D 195941.00 D Common Stock 1550.00 I By Child 1 Common Stock 1550.00 I By Child 2 Common Stock 1550.00 I By Child 3 Common Stock 1000.00 I By Spouse The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020. This transaction was executed in multiple trades at prices ranging from $98.49 to $98.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $96.06 to $97.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $97.45 to $98.42. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $98.51 to $99.08. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $93.88 to $94.69. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $94.89 to $95.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $96.11 to $96.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $97.45 to $98.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020. This transaction was executed in multiple trades at prices ranging from $98.50 to $99.08 The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $94.89 to $95.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $96.16 to $96.89. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ Angela Ahmad, attorney-in-fact for Andrew Hykes 2021-01-20